Hepatocellular Carcinoma Surveillance in Cirrhotics

NACompletedINTERVENTIONAL
Enrollment

615

Participants

Timeline

Start Date

November 19, 2020

Primary Completion Date

November 26, 2021

Study Completion Date

February 14, 2022

Conditions
Hepatocellular CarcinomaCirrhosis
Interventions
BEHAVIORAL

Usual care

Subjects will receive outreach through their providers as is standard of care.

BEHAVIORAL

Opt-out

Research staff will send a letter to patients encouraging them to get a surveillance ultrasound and include an order slip for them to get it done at a health system facility.

BEHAVIORAL

Opt-out + Incentive

Research staff will send a letter to patients encouraging them to get a surveillance ultrasound and include an order slip plus an unconditional $20 incentive for them to get it done at a health system facility.

Trial Locations (1)

19104

University of Pennsylvania Health System, Philadelphia

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

University of Pennsylvania

OTHER

NCT04248816 - Hepatocellular Carcinoma Surveillance in Cirrhotics | Biotech Hunter | Biotech Hunter